Keywords: Pfizer, Hisun Pharma, China, Low-cost genreics, Clovis Oncology, PARP inhibitor, Solid tumors

Pfizer pencils JV deal with Hisun for low-cost generics in China; out-licenses drug to Clovis

Article | 03 June 2011

Print This

The world’s largest pharma company, USA-based Pfizer (NYSE: PFE), has entered into a memorandum of understanding with leading ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in